[Asia Economy Reporter Park Jihwan] SK Biopharm announced on the 25th that it has signed a pharmaceutical supply contract worth 11.3 billion KRW with its subsidiary SK Life Science.
The contract amount corresponds to 43.51% of recent sales revenue.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
